Protara Therapeutics, Inc. (TARA)
TARA Stock Price Chart
Explore Protara Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze TARA price movements and trends.
TARA Company Profile
Discover essential business fundamentals and corporate details for Protara Therapeutics, Inc. (TARA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Oct 2014
Employees
28.00
Website
https://www.protaratx.comCEO
Jesse Shefferman
Description
Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains. The company's leading therapeutic candidate, TARA-002, is an investigational cellular therapy currently under evaluation for the treatment of lymphatic malformations. Furthermore, Protara is developing intravenous choline chloride, a potential phospholipid substrate replacement therapy aimed at addressing liver disease associated with intestinal failure. The organization, which was formerly known as ArTara Therapeutics, Inc., underwent a name change to Protara Therapeutics, Inc. in May 2020. Its principal operations are based in New York, New York.
TARA Financial Timeline
Browse a chronological timeline of Protara Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Aug 2026
EPS estimate is -$0.33.
Earnings released on 13 May 2026
EPS came in at -$0.31 surpassing the estimated -$0.36 by +13.89%.
Earnings released on 10 Mar 2026
EPS came in at -$0.37 falling short of the estimated -$0.32 by -15.62%.
Earnings released on 10 Nov 2025
EPS came in at -$0.31 surpassing the estimated -$0.39 by +20.51%.
Earnings released on 11 Aug 2025
EPS came in at -$0.35 surpassing the estimated -$0.43 by +18.60%.
Earnings released on 8 May 2025
EPS came in at -$0.29 surpassing the estimated -$0.47 by +38.30%.
Earnings released on 5 Mar 2025
EPS came in at -$0.48 surpassing the estimated -$0.57 by +15.79%.
Earnings released on 12 Nov 2024
EPS came in at -$0.50 matching the estimated -$0.50.
Earnings released on 6 Aug 2024
EPS came in at -$0.45 surpassing the estimated -$0.82 by +45.12%.
Earnings released on 2 May 2024
EPS came in at -$0.97 surpassing the estimated -$0.99 by +2.02%.
Earnings released on 13 Mar 2024
EPS came in at -$0.90 surpassing the estimated -$1.03 by +12.62%, while revenue for the quarter reached $1.21m .
Earnings released on 3 Nov 2023
EPS came in at -$0.87 surpassing the estimated -$1.10 by +20.91%.
Earnings released on 3 Aug 2023
EPS came in at -$1.00 falling short of the estimated -$0.97 by -3.09%.
Earnings released on 4 May 2023
EPS came in at -$0.80 surpassing the estimated -$1.00 by +20.00%.
Earnings released on 8 Mar 2023
EPS came in at -$0.84 falling short of the estimated -$0.77 by -9.09%.
Earnings released on 3 Nov 2022
EPS came in at -$0.68 surpassing the estimated -$0.85 by +20.00%.
Earnings released on 9 Aug 2022
EPS came in at -$0.80 surpassing the estimated -$1.13 by +29.20%.
Earnings released on 5 May 2022
EPS came in at -$0.96 surpassing the estimated -$1.09 by +11.93%.
Earnings released on 9 Mar 2022
EPS came in at -$0.91 surpassing the estimated -$0.94 by +3.19%.
Earnings released on 4 Nov 2021
EPS came in at -$0.96 surpassing the estimated -$1.15 by +16.52%.
Earnings released on 5 Aug 2021
EPS came in at -$1.14 matching the estimated -$1.14.
TARA Stock Performance
Access detailed TARA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
